Logger Script
바로가기 및 건너띄기 링크
본문 바로가기
주메뉴 바로가기


논문 주제별검색 기관별검색

당뇨 환자의 체중감량을 위한 가미태음조위탕의 임상적 활용: 후향적 차트 리뷰

Gamitaeeumjowee-Tang for weight loss in diabetic patients: A retrospective chart review

이아름 (경희대학교 대학원) ,   이다연 ( 누베베 한의원) ,   김민지 ( 누베베 한의원) ,   이향숙 ( 경희대학교 대학원) ,   최가혜 ( 누베베 한의원, 누베베 미병 연구소) ,   김서영 ( 누베베 한의원, 누베베 미병 연구소) ,   임영우 ( 누베베 한의원, 누베베 미병 연구소) ,   박영배 ( 누베베 미병 연구소)

당뇨 환자의 체중감량을 위한 가미태음조위탕의 임상적 활용: 후향적 차트 리뷰 - 저널명, 기관명, ISSN, 발행일, 권호, 페이지, 조회수, ISBN 정보 안내
저널명 大韓韓醫學會誌  기관명 대한한의학회 
ISSN 10100695  발행일 2021-03-01 
권호 제 42권 제 1호  페이지 46-58 
조회수 122  ISBN  

초록

한글초록

한글 초록 없음

영어초록

Objectives:
The purpose of this study is to report weight changes and analyze adverse events in diabetic patients with Gamitaeeumjowee-Tang for weight loss.
Methods:
A retrospective chart review of weight change and adverse events was performed during the 10-week weight loss program using Gamitaeeumjowee-tang with low-calorie diets for diabetics(n=61). Weight and BMI changes were compared before and after the program and calculated the percentage of people who lost more than 5% of their weight, also identified whether subjects felt satiated or not. Adverse events were evaluated in terms of causality, severity and system-organ classes.
Results:
After 10-week weight loss program, significant weight loss (5.9±2.32㎏, 7.73% reduction from baseline) and BMI reduction (2.9±0.86) were reported (n=61). Those who lost more than 5 percent of their body weight accounted for 88.5%, and also 88.5% of the participants felt full to help control their appetite. In assessing the causality of adverse events, 'Unlikely' was the most common (66%) and in severity evaluations, almost all symptoms were mild. Insomnia was the most frequently reported during the first 8 weeks, and constipation was reported the most afterwards.
Conclusions:
A combination of Gamitaeeumjowee-tang and low-calorie diets for 10 weeks appears to help weight reduction without serious adverse events in diabetic patients. Future well-designed prospective clinical studies testing the effectiveness and safety of this weight loss program are warranted.

열기 접기

참고문헌

이 논문의 참고문헌이 39 건이 있습니다.

1. Korean Diabetes Association, Treatment Guideline for Diabetes, Korean Diabetes Association (2018), 13, 17
2. Jang HC, Choi SH, Characterization of Patients with Type 2 Diabetes according to Body Mass Index: Korea National Health and Nutrition Examination Survey from 2007 to 2011, Endocrinol Metab (2015), Vol 30, 514-521
3. Korean Obesity Association, Treatment Guideline for Obesity, Korean Obesity Association (2018), 17-18
4. Korean Diabetes Association, Diabetes Fact Sheet, Korean Diabetes Association (2018)
5. Torgerson JS, Hauptman J, Boldrin MN 외 1 명, XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients, Diabetes Care (2004), Vol 27, 155-161
6. Wing RR, Lang W, Wadden TA 외 3 명, et al., Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes, Diabetes Care (2011), Vol 34, 1481-1486
7. Kim DH, Park SC, Lee JH 외 3 명, et al., Recent Research Trends in Korean Medicine Treatment of Diabetes Mellitus - Focusing on Domestic Articles from 2008 to 2013 -, Korean Journal Orient Int Med (2013), Vol 4-3, 240-255
8. Hanefeld M, Fischer S, Schmechel H 외 3 명, et al., Diabetes Intervention Study, Multi-intervention trial in newly diagnosed NIDDM, Diabetes Care (1991), Vol 14, 308-317
9. United Kingdom Prospective Diabetes Study (UK-PDS), 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years, BMJ (1995), Vol 310, 83-88
10. Lee MJ, Kim SS, Management of Obesity in Patients with Diabetes Mellitus, Journal Korean Diabetes (2017), Vol 18, 229-238
11. Chon S, Park CY, Koh GP 외 3 명, et al., The Effect of Orlistat in Obese Patients with Type 2 Diabetes : Benefit on Abdominal Obesity and Glycemic Control, Journal Korean Med Obes Res (2004), Vol 13-4, 281-292
12. Lee EJ, Kim TN, Pharmacological Management of Obesity in Patients with Type 2 Diabetes: An Update, Korean Journal Obes (2016), Vol 25-3, 121-128 DOI 참고문헌
13. O’Neil PM, Smith SR, Weissman NJ 외 3 명, et al., Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study, Obesity (2012), Vol 20, 1426-1436
14. Hollander P, Gupta AK, Plodkowski R 외 3 명, et al., Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes, Diabetes Care (2013), Vol 36, 4022-4029
15. Davies MJ, Bergenstal R, Bode B 외 3 명, et al., Efficacy of liraglutide for weight loss among patients with type 2 diabetes: The SCALE diabetes randomized clinical trial, JAMA (2015), Vol 314, 687-699
16. Han HJ, Kim HJ, Park EY 외 3 명, et al., The effect of oriental obesity therapy on Morbid obese patient with Type 2 Diabetes : Two Cases Report, Journal Korean Med (2010), Vol 10, 57-63
17. Kim HJ, Kim KS, Improvement of type 2 diabetes by very-low-calorie diet-A case report, Journal Korean Med (2002), Vol 2-1, 97-102 DOI 참고문헌
18. Cha YY, A case Study on the Treatment of Obese patient with diabetes, Journal Korean Med (2004), Vol 4-1, 193-199
19. World Health Organization-Uppsala Monitoring Centre (WHO-UMC), Causality categories [Internet], World Health Organization-Uppsala Monitoring Centre (WHO-UMC) (2018), https://who-umc.org/media/164200/who-umc-causality-assessment_new-logo.pdf
20. Korea Institute of Drug Safety & Risk Management, Adverse Drug Reaction Assessment Report. 1st ed, Korea Institute of Drug Safety & Risk Management (2013), 60-63
21. National Cancer Institute, National Institute of Health, U.S.DEPARTMENT OF HEALTH AND HUMAN SERVICES, Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, National Cancer Institute, National Institute of Health, U.S.DEPARTMENT OF HEALTH AND HUMAN SERVICES (2010)
22. Basch E, Reeve B, Mitchell S 외 3 명, et al., Development of the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) (2014), Vol 106-9, 244
23. Korea Institute of Drug Safety & Risk Management, Terminology Guide for Reporting Adverse Drug Reactions, Korea Institute of Drug Safety & Risk Management (2014), 1-6
24. Lee JM, Longevity and life preservation in Eastern medicine, Haklimsa (1986), 333-338
25. Lee JE, Song YK, Lim HH, Clinical trial of Taeeumjowui-tang (Taiyintiaowei-tang) on obese patients: randomized, double blind, placebo-controlled study, Journal Orient Rehab Med (2010), Vol 20-4, 197-213
26. Lim SY, Park SW, Joo JH 외 3 명, The effects of Taeeumjowui-tang (Taiyintiaowei-tang) on obesity in Sasang constitution, Journal East-West Med (2012), Vol 37-4, 109-116
27. Park SJ, Nahmkoong W, Cheon CH 외 3 명, et al., Efficacy and safety of Taeeumjowi-tang in obese Korean adults: a double-blind, randomized, and placebo-controlled pilot trial, Evid-Based Complement Altern Med (2013), Vol 2013, 498935
28. Hwang MJ, Shin HD, Song MY, Literature review of herbal medicines on treatment of obesity since 2000; mainly about Ephedra Herba, Journal Korean Med Obes Res (2007), Vol 7-1, 39-54
29. Jang IS, Hwang EH, The Need for Clinical Practice Guidelines in Usage of Mahuang in Weight Loss, Journal Korean Med Obes Res (2007), Vol -1, 23-29
30. Jo GW, Ok JM, Kim SY 외 1 명, Review on the efficacy and safety of Mahuang and ephedrine in the treatment of obesity-focused on RCT, Journal Korean Med (2017), Vol 38-3, 170-184 DOI 참고문헌
31. Wing RR, Marcus MD, Epstein LH 외 1 명, A “family-based” approach to the treatment of of obese Type Ⅱ diabetic patients, Journal Consult Clin Psychol (1991), Vol 59, 156-162
32. Yoon NR, Yoo YJ, Kim MJ 외 3 명, et al., Analysis of Adverse Events in Weight Loss Program in Combination with ‘Gamitaeeumjowee-Tang’ and Low-Calorie Diet, Journal Korean Med Obes Res (2018), Vol 18-1, 1-9 DOI 참고문헌
33. Kim HJ, Kim JY, Clinical report about the adverse reactions of Taeeumin·Soeumin·Soyangin by Taeeumjowi-tang, Korean Journal Oriental Physiology & Pathology (2008), Vol 22-6, 1600-1605
34. Luyster FS, Dunbar-Jacob J, Sleep quality and quality of life in adults with type 2 diabetes, Diabetes Educ (2011), Vol 379, 347-355
35. Jain A, Sharmab R, Yadavc N 외 3 명, Quality of life and its association with insomnia and clinical variables in type 2 diabetes, Journal Egypt Public Health Assoc (2017), Vol 92-1, 52-59 DOI 참고문헌
36. Attarian H, Hachul H, Guttuso T 외 1 명, Treatment of chronic insomnia disorder in menopause: Evaluation of literature, Menopause (2015), Vol 22-6, 674-684 DOI 참고문헌
37. Kim Hwa, Diagnosis and Management of Diabetic Autonomic Neuropathy Chong, Journal Korean Diabetes (2018), Vol 19, 160-167
38. Christensen P, Bliddal H, Riecke BF 외 3 명, Comparison of a low-energy diet and a very low-energy diet in sedentary obese individuals: a pragmatic randomized controlled trial, Clin Obes (2011), Vol 1-1, 31-34 DOI 참고문헌
39. Kim JS, Yoon SH, Effect of Naesosan gastric motility between normal intact and antral dilatated rats, Journal Korean Orient Int Med (2008), Vol 29-1, 117-129

열기 접기